Evaluation of Olopatadine, a New Ophthalmic Antiallergic Agent with Dual Activity, Using the Conjunctival Allergen Challenge Model
- 30 September 1998
- journal article
- clinical trial
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 81 (3) , 211-218
- https://doi.org/10.1016/s1081-1206(10)62814-1
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- TheIn VitroandIn VivoOcular Pharmacology of Olopatadine (AL-4943A), an Effective Anti-Allergic/Antihistaminic AgentJournal of Ocular Pharmacology and Therapeutics, 1996
- Evaluation of 0.05% Levocabastine versus 4% Sodium Cromolyn in the Allergen Challenge ModelOphthalmology, 1995
- Allergic conjunctivitis and uveitis models: Reappraisal with some marketed drugsInflammation Research, 1995
- Evaluation of the new ophthalmic antihistamine, 0.05% levocabastine, in the clinical allergen challenge model of allergic conjunctivitisJournal of Allergy and Clinical Immunology, 1994
- Conjunctivitis of allergic origin: Immunologic mechanisms and current approaches to therapySurvey of Ophthalmology, 1993
- Precision of conjunctival provocation tests in right and left eyesJournal of Allergy and Clinical Immunology, 1993
- Randomised Double-Masked Trial of Lodoxamide and Sodium Cromoglycate in Allergic Eye DiseaseEuropean Journal of Ophthalmology, 1992
- Allergic Conjunctivitis: A Survey of New AntihistaminesJournal of Ocular Pharmacology and Therapeutics, 1991
- Conjunctival Allergen ChallengeArchives of Ophthalmology (1950), 1990
- H2-Receptors in the Human Ocular SurfaceArchives of Ophthalmology (1950), 1981